EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Plasma protein profile in patients with antiphospholipid syndrome and controls without antiphospholipid syndrome

Dagmar J M van Mourik, Britte F van der Vliet, Dorien Salet, L Renee Ruhaak, Natasja Dolezal, Jan Wouter Drijfhout, Robert A Cordfunke, Astrid van Hylckama Vlieg, Frederikus A Klok, Michiel Coppens, Mettine H A Bos, Saskia Middeldorp und 3 weitere

Journal of Thrombosis and Haemostasis · 2026-11 · 24 (11) · 4027-4035

DOI: 10.1016/j.jtha.2026.08.019 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Thrombosis and Haemostasis, 2026-11. Verfasst von Dagmar J M van Mourik und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Division of Thrombosis & Hemostasis, Leiden University Medical Center, Leiden, Netherlands; Einthoven Laboratory for Vascular…. Hauptthemen laut MEDLINE: Antiphospholipid Syndrome, Blood Proteins, Proteomics. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Hartstichting.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Antiphospholipid syndrome (APS) is a thrombotic autoimmune disease associated with persistent presence of antiphospholipid antibodies. A range of mechanisms have been implicated in the clinical manifestations of APS, but it is unclear which processes are dominant in vivo, although all mechanisms take place in the circulation. Exploring the plasma protein profile may provide leads for further research. OBJECTIVES: This study assessed plasma protein abundances in patients with clinically stable APS compared with controls without APS across 2 cohorts. METHODS: The discovery cohort included 61 APS patients and 19 controls, and the verification cohort included 77 APS patients and 49 controls. Quantitative protein mass spectrometry was used to measure 159 plasma proteins, including proteins involved in blood coagulation, complement pathway, transport, apolipoproteins, and immunity. Proteins were quantified in plasma with use of stable isotope-labeled peptide standards. Data were analyzed using a Welch t-test. Ten proteins with the lowest P value from the discovery cohort were selected for validation in the verification cohort. RESULTS: Of the 10 selected proteins, 6 were differentially abundant between APS patients and controls without APS in the verification cohort and showed consistent fold changes across both cohorts: alpha-1-acid glycoprotein 1, beta-2-microglobulin, complement C2, insulin-like growth factor-binding protein complex acid labile subunit, leucine-rich alpha-2-glycoprotein 1, and cystatin-C. CONCLUSION: We identified 6 plasma proteins that were differentially abundant in APS patients compared with controls without APS and confirmed these associations in an independent verification cohort. Collectively, these proteins may reflect subclinical inflammation and renal involvement in APS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antiphospholipid SyndromeBlood ProteinsProteomicsHumansFemaleMaleAdultMiddle AgedCase-Control StudiesBiomarkersMass SpectrometryReproducibility of Results

Stichwörter der Autor:innen

antiphospholipid syndromeblood proteinsliquid chromatography–mass spectrometryproteomeproteomics

Substanzen

Blood ProteinsBiomarkers

Autor:innen und Institutionen

  • Department of Medicine, Division of Thrombosis & Hemostasis, Leiden University Medical Center, Leiden, Netherlands; Einthoven Laboratory for Vascular and Regenerative Medicine, Leiden University Medical Center, Leiden,…
  • Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, Netherlands.
  • Department of Vascular Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands; Department of Internal Medicine, Radboud University Medical Center, Nijmegen, Netherlands.
  • Department of Clinical Chemistry and Laboratory Medicine, Leiden University Medical Center, Leiden, Netherlands.
  • Department of Immunology, Leiden University Medical Center, Leiden, Netherlands.
  • Department of Medicine, Division of Thrombosis & Hemostasis, Leiden University Medical Center, Leiden, Netherlands.

Förderung

  • Hartstichting

Zitieren

APA

van Mourik, D. J. M., van der Vliet, B. F., Salet, D., Ruhaak, L. R., Dolezal, N., Drijfhout, J. W., Cordfunke, R. A., van Hylckama Vlieg, A., Klok, F. A., Coppens, M., Bos, M. H. A., Middeldorp, S., Eikenboom, J. C. J., van Vlijmen, B. J. M., & van Mens, T. E. (2026). Plasma protein profile in patients with antiphospholipid syndrome and controls without antiphospholipid syndrome. Journal of Thrombosis and Haemostasis, 24(11), 4027-4035. https://doi.org/10.1016/j.jtha.2026.08.019

Vancouver

van Mourik DJM, van der Vliet BF, Salet D, Ruhaak LR, Dolezal N, Drijfhout JW, et al. Plasma protein profile in patients with antiphospholipid syndrome and controls without antiphospholipid syndrome. Journal of Thrombosis and Haemostasis. 2026;24(11):4027-4035. doi:10.1016/j.jtha.2026.08.019

BibTeX
@article{vanMourik2026,
  author = {van Mourik, Dagmar J M and van der Vliet, Britte F and Salet, Dorien and Ruhaak, L Renee and Dolezal, Natasja and Drijfhout, Jan Wouter and Cordfunke, Robert A and van Hylckama Vlieg, Astrid and Klok, Frederikus A and Coppens, Michiel and Bos, Mettine H A and Middeldorp, Saskia and Eikenboom, Jeroen C J and van Vlijmen, Bart J M and van Mens, Thijs E},
  title = {Plasma protein profile in patients with antiphospholipid syndrome and controls without antiphospholipid syndrome},
  journal = {Journal of Thrombosis and Haemostasis},
  year = {2026},
  volume = {24},
  number = {11},
  pages = {4027--4035},
  doi = {10.1016/j.jtha.2026.08.019}
}
Kostenlos starten →